Leddy, John J.
Haider, Mohammad Nadir
Noble, James M.
Rieger, Brian
Flanagan, Steven
McPherson, Jacob I.
Shubin-Stein, Kenneth
Saleem, Ghazala T.
Corsaro, Louis
Willer, Barry
Article History
Accepted: 23 October 2021
First Online: 24 November 2021
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: John J Leddy, Flanagan Steven, Jacob I McPherson, Kenneth Shubin-Stein, Ghazala T. Saleem, Louis Corsaro, and Barry Willer each declare no potential conflicts of interest.James M. Noble is the co-founder and chief medical officer of NoMo Diagnostics, which aims to develop an EEG-based concussion diagnostic tool; he has stock options in the company. Dr. Noble is co-inventor of a device with patent under review (Columbia University). Its use is not discussed or advised in the manuscript. In addition, Dr. Noble has a patent US20190298262A1 pending. The patent's use is licensed to NoMo Diagnostics.Mohammad Nadir Haider has received personal fees from BlinkCNS and Oculogica Inc.Brian Rieger reports equity interest in Quadrant Biosciences (Motion Intelligence), and is Co-Chair, Brain Injury Association of New York State—Concussion Initiative.
: This article does not contain any studies with human or animal subjects performed by any of the authors.